{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Solriamfetol+Oral+Tablet", "query": { "intervention": "Solriamfetol Oral Tablet" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 13, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Solriamfetol+Oral+Tablet&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-24T14:37:30.266Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06878976", "title": "A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating Disorder", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Binge-Eating Disorder" ], "interventions": [ { "name": "Solriamfetol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "56 Years", "sex": "ALL", "summary": "18 Years to 56 Years" }, "enrollment_count": 236, "start_date": "2025-02-20", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-08-11", "last_synced_at": "2026-09-24T14:37:30.266Z", "location_count": 33, "location_summary": "Encino, California • Long Beach, California • Santa Ana, California + 28 more", "locations": [ { "city": "Encino", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "West Covina", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06878976" }, { "nct_id": "NCT06360419", "title": "Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Solriamfetol 300 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 346, "start_date": "2024-03-18", "completion_date": "2025-03-26", "has_results": false, "last_update_posted_date": "2026-01-05", "last_synced_at": "2026-09-24T14:37:30.266Z", "location_count": 40, "location_summary": "Little Rock, Arkansas • Bellflower, California • Encino, California + 35 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Lemon Grove", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06360419" }, { "nct_id": "NCT05008341", "title": "Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Narcolepsy", "Obstructive Sleep Apnea", "Excessive Daytime Somnolence", "Excessive Sleepiness", "Postpartum" ], "interventions": [ { "name": "Solriamfetol 150 mg Oral Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 6, "start_date": "2021-08-27", "completion_date": "2022-04-15", "has_results": false, "last_update_posted_date": "2023-04-14", "last_synced_at": "2026-09-24T14:37:30.266Z", "location_count": 1, "location_summary": "Raleigh, North Carolina", "locations": [ { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05008341" }, { "nct_id": "NCT06568367", "title": "Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Excessive Sleepiness", "Shift-work Disorder" ], "interventions": [ { "name": "Solriamfetol 150 mg", "type": "DRUG" }, { "name": "Solriamfetol 300 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 520, "start_date": "2024-08-01", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-09-24T14:37:30.266Z", "location_count": 44, "location_summary": "Auburn, Alabama • Cullman, Alabama • Chandler, Arizona + 37 more", "locations": [ { "city": "Auburn", "state": "Alabama" }, { "city": "Cullman", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06568367" }, { "nct_id": "NCT02348593", "title": "\"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy\"", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Narcolepsy" ], "interventions": [ { "name": "JZP-110", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 239, "start_date": "2015-05", "completion_date": "2017-02", "has_results": true, "last_update_posted_date": "2019-07-23", "last_synced_at": "2026-09-24T14:37:30.266Z", "location_count": 45, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Scottsdale, Arizona + 38 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02348593" }, { "nct_id": "NCT06404086", "title": "RECOVER-SLEEP: Platform Protocol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Long COVID", "Long COVID-19", "Hypersomnia", "Sleep Disturbance" ], "interventions": [ { "name": "Modafinil", "type": "DRUG" }, { "name": "Modafinil Placebo", "type": "DRUG" }, { "name": "Solriamfetol", "type": "DRUG" }, { "name": "Solriamfetol Placebo", "type": "DRUG" }, { "name": "Melatonin", "type": "DRUG" }, { "name": "Melantonin Placebo", "type": "DRUG" }, { "name": "Tailored lighting (TL) Active", "type": "DEVICE" }, { "name": "Tailored lighting (TL) Placebo", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 830, "start_date": "2024-07-31", "completion_date": "2025-12-31", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-09-24T14:37:30.266Z", "location_count": 47, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Palo Alto, California + 31 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06404086" }, { "nct_id": "NCT07484217", "title": "Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms" ], "interventions": [ { "name": "Solriamfetol 150 MG", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 508, "start_date": "2026-02-23", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-09-24T14:37:30.266Z", "location_count": 40, "location_summary": "Tucson, Arizona • Bellflower, California • Chino, California + 33 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Bellflower", "state": "California" }, { "city": "Chino", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Imperial", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07484217" }, { "nct_id": "NCT05838430", "title": "Solriamfetol and CBT-I in Patients With Insomnia Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Insomnia" ], "interventions": [ { "name": "Solriamfetol 75 MG", "type": "DRUG" }, { "name": "Cognitive Behavioral Therapy for Insomnia (CBT-I)", "type": "BEHAVIORAL" }, { "name": "Monitoring", "type": "OTHER" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "OTHER" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "25 Years to 60 Years" }, "enrollment_count": 115, "start_date": "2023-07-31", "completion_date": "2026-04-30", "has_results": false, "last_update_posted_date": "2026-05-12", "last_synced_at": "2026-09-24T14:37:30.266Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05838430" }, { "nct_id": "NCT02348606", "title": "\"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA\"", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obstructive Sleep Apnea" ], "interventions": [ { "name": "JZP-110", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 476, "start_date": "2015-05", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2019-07-23", "last_synced_at": "2026-09-24T14:37:30.266Z", "location_count": 45, "location_summary": "Glendale, Arizona • Scottsdale, Arizona • Little Rock, Arkansas + 38 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02348606" }, { "nct_id": "NCT04622293", "title": "A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Fatigue Syndrome", "Myalgic Encephalomyelitis" ], "interventions": [ { "name": "Solriamfetol Oral Tablet [Sunosi]", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rochester Center for Behavioral Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 44, "start_date": "2021-04-27", "completion_date": "2024-12-01", "has_results": false, "last_update_posted_date": "2025-04-06", "last_synced_at": "2026-09-24T14:37:30.266Z", "location_count": 1, "location_summary": "Rochester Hills, Michigan", "locations": [ { "city": "Rochester Hills", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04622293" } ] }